The life sciences sector is made up of a diverse ecosystem of companies and segments. They range from massive global pharma companies and regional lab powerhouses to small startup device manufacturers and innovative biotech research labs. No two life sciences companies face the same challenges or opportunities. And there is no ‘typical’ life sciences CEO.

The 2024 KPMG Life Sciences CEO Outlook, a survey of 120 life sciences CEOs from around the world suggests there are common themes and strategies at play. As life sciences organisations across the spectrum focus on driving innovation, many are struggling to accelerate digitalisation and the adoption of AI. They recognise the importance of environmental, social and governance (ESG) on public trust and growth but aren’t sure they can meet their net zero objectives. Talent gaps and capability shortages emerge as continuous themes throughout.

Get in touch

Unlock the potential within your organisation with insights from our latest Life Sciences CEO Outlook. At KPMG, we understand the unique challenges and opportunities in the life sciences sector. Whether you need strategic advice, regulatory support, or growth strategies, our experts are ready to assist.

Contact Brian Egan of our Life Sciences team for an initial conversation; we'd be delighted to hear from you.

Discover more in Life Sciences